0
Signin
countryflagUK

8082-737-676

0R15 8432.9941 0.3331% 0R1E 7697.9961 -2.8767% 0M69 None None% 0R2V 220.12 9997.2477% 0QYR 1224.0 -0.6897% 0QYP 408.94 -0.0147% 0RUK 2670.0 -8.6242% 0RYA 1370.0 9.6% 0RIH 162.15 0.0% 0RIH 156.61 -3.4166% 0R1O 173.7 9825.7143% 0R1O None None% 0QFP 10659.5596 111.4992% 0M2Z 282.6 2.979% 0VSO 27.48 -22.8198% 0R1I None None% 0QZI 512.5 -2.1947% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 153.89 -0.7737%

Aptamer Group PLC

Healthcare GB APTA

0.24GBP
-(-%)

Last update at 2024-09-04T15:35:00Z

52 Week Range

1.0257.50
LowHigh

Fundamentals

  • Previous Close 0.24
  • Market Cap5.49M
  • Volume373440
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.15500M
  • Revenue TTM1.75M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 2.69M
  • Diluted EPS TTM-0.11

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-03-31 2019-03-31
Income before tax -8.29800M -2.63800M - -0.94129M -0.59483M
Minority interest - - - - -
Net income -7.83600M -2.09300M - -0.67473M -0.45498M
Selling general administrative 5.03M 4.35M - 1.17M 1.03M
Selling and marketing expenses - - - 0.00867M 0.00273M
Gross profit 0.36M 2.69M - 0.46M 0.61M
Reconciled depreciation 0.80M 0.45M - 0.19M 0.16M
Ebit -5.56300M -2.59100M -2.29760M -0.92205M -0.54024M
Ebitda -4.76300M -2.13700M - -0.73359M -0.38267M
Depreciation and amortization 0.80M 0.45M - 0.19M 0.16M
Non operating income net other - - - - -
Operating income -8.15700M -2.57600M - -0.92205M -0.54024M
Other operating expenses 9.91M 6.61M -0.00400M 1.78M 1.53M
Interest expense 0.13M 0.05M - 0.01M 0.00744M
Tax provision -0.46200M -0.54500M - -0.26656M -0.13985M
Interest income - - - 0.00004M 0.00005M
Net interest income -0.13400M -0.04800M - -0.01327M -0.00913M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.46200M -0.54500M -0.47840M -0.26656M -0.13985M
Total revenue 1.75M 4.04M - 0.85M 0.99M
Total operating expenses 8.52M 5.26M - 1.38M 1.15M
Cost of revenue 1.39M 1.35M - 0.40M 0.37M
Total other income expense net -0.14100M -0.06200M - -0.01924M -0.05459M
Discontinued operations - - - - -
Net income from continuing ops -7.83600M -2.09300M - -0.67473M -0.45498M
Net income applicable to common shares - -2.09300M -1.84960M -0.67473M -0.45498M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-03-31 2019-03-31
Total assets 2.75M 11.52M - 1.39M 1.40M
Intangible assets 0.07M 0.34M - 0.02M 0.02M
Earning assets - - - - -
Other current assets - 1.87M - 0.64M 0.45M
Total liab 2.45M 3.47M - 1.14M 0.50M
Total stockholder equity 0.30M 8.05M - 0.25M 0.90M
Deferred long term liab - - - - -
Other current liab 0.26M 1.61M 0.60M 0.76M 0.35M
Common stock 0.07M 0.07M 0.03M 0.03M 0.03M
Capital stock 0.07M 0.07M - 0.03M 0.03M
Retained earnings -10.07200M -2.31400M -5.39600M -3.08457M -2.40984M
Other liab - 0.04M 0.03M 0.02M 0.01M
Good will - - - - -
Other assets - 0.38M - - -
Cash 0.23M 6.69M - 0.29M 0.73M
Cash and equivalents - - - - -
Total current liabilities 1.64M 2.37M 1.86M 1.09M 0.48M
Current deferred revenue 0.67M - - - -
Net debt -0.16500M -5.38300M - -0.13217M -0.65559M
Short term debt 0.05M 0.25M - 0.13M 0.07M
Short long term debt 0.05M 0.04M - 0.00000M 0.00000M
Short long term debt total 0.07M 1.31M - 0.16M 0.07M
Other stockholder equity 10.31M 10.30M 0.27M 3.30M 3.28M
Property plant equipment - 1.82M 0.52M 0.37M 0.15M
Total current assets 1.59M 8.98M 1.32M 1.00M 1.23M
Long term investments - - - - -
Net tangible assets - 7.71M -0.11700M 0.23M 0.88M
Short term investments - - - - -
Net receivables 0.36M 0.63M 0.85M 0.30M 0.20M
Long term debt 0.02M 0.00000M - 0.00000M 0.00000M
Inventory 0.20M 0.42M 0.09M 0.07M 0.06M
Accounts payable 0.66M 0.51M 0.54M 0.20M 0.06M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.37M 0.38M - - -
Deferred long term asset charges - - - - -
Non current assets total 1.16M 2.54M - 0.39M 0.16M
Capital lease obligations 1.01M 1.27M - 0.16M 0.07M
Long term debt total - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-03-31 2019-03-31
Investments -2.02800M -0.41800M - -0.16079M -0.04077M
Change to liabilities - 0.45M 0.57M 0.55M -0.50740M
Total cashflows from investing activities - -0.41800M -0.33920M -0.16079M -0.04077M
Net borrowings - -0.40500M -0.16240M -0.17123M -0.12482M
Total cash from financing activities -0.36500M 9.12M 1.50M -0.19051M 1.41M
Change to operating activities - - - 0.00500M 0.00500M
Net income -7.83600M -2.09300M -1.84960M -0.67473M -0.45498M
Change in cash -6.45700M 6.32M 0.06M -0.43401M 0.53M
Begin period cash flow 6.69M 0.37M 0.29M 0.73M 0.20M
End period cash flow 0.23M 6.69M 0.37M 0.29M 0.73M
Total cash from operating activities -4.06400M -2.37500M -1.09920M -0.08271M -0.84493M
Issuance of capital stock 0.00500M 9.58M - 0.00000M 1.55M
Depreciation 0.80M 0.45M 0.24M 0.19M 0.16M
Other cashflows from investing activities - - - 0.00004M 0.00005M
Dividends paid - - - - -
Change to inventory 0.22M -0.33000M -0.01600M -0.01082M 0.01M
Change to account receivables - -1.43300M 0.08M -0.06214M 0.06M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.33300M -0.46700M -0.03120M -0.16079M -0.13687M
Change to netincome - 0.64M -0.15040M -0.08681M -0.12056M
Capital expenditures 2.03M 0.42M 0.16M 0.16M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.07M -1.31800M - 0.48M -0.43154M
Stock based compensation 0.08M 0.46M - 0.02M 0.00346M
Other non cash items 0.13M 0.05M - 0.02M 0.01M
Free cash flow -6.09200M -2.79300M - -0.24354M -0.88575M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
APTA
Aptamer Group PLC		 - -% 0.24 - - 3.20 18.45 3.68 -1.3541
ONT
Oxford Nanopore Technologies Ltd		 0.10 0.07% 140.90 - - 10.88 2.75 8.77 -16.7946
GNS
Genus PLC		 -16.9139 0.94% 1777.09 42.59 25.71 2.08 2.46 2.31 16.39
PRTC
PureTech Health plc		 2.82 1.81% 159.22 - - 35.55 1.04 95.87 -4.5333
AVCT
Avacta Group PLC		 -0.55 0.76% 71.65 - - 23.19 14.78 20.75 -10.4566

Reports Covered

Stock Research & News

View All

Profile

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, and internationally. The company offers Optimer platform that enables the discovery and development of oligonucleotide binders; custom development services for oligonucleotide-based aptamer and Optimer binders; solutions to bioprocessing, diagnostic, and pharmaceutical scientists; and contract research services in the field of therapeutics. It serves pharma companies, diagnostic development companies, and research institutes. Aptamer Group plc was founded in 2008 and is headquartered in York, the United Kingdom.

Aptamer Group PLC

Windmill House, York, United Kingdom, YO10 5BR

Key Executives

Name Title Year Born
Dr. Arron C. Tolley CEO, Member of the Scientific Advisory Board & Exec. Director NA
Ms. Jennifer Cutler Interim CFO & Company Sec. NA
Mr. Alastair Fleming Chief Operating Officer NA
Dr. David Bunka CTO, Member of the Scientific Advisory Board & Exec. Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions